Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Absence of Evidence for Sustained Effects of Daily Cannabidiol Administration on Anandamide Plasma Concentration in Individuals with Cocaine Use Disorder: Exploratory Findings from a Randomized Controlled Trial.
Hebert FO, Mongeau-Pérusse V, Rizkallah E, Mahroug A, Bakouni H, Morissette F, Brissette S, Bruneau J, Dubreucq S, Jutras-Aswad D. Hebert FO, et al. Among authors: rizkallah e. Cannabis Cannabinoid Res. 2024 May 21. doi: 10.1089/can.2023.0273. Online ahead of print. Cannabis Cannabinoid Res. 2024. PMID: 38770686
Two polygenic mouse models of major depressive disorders identify TMEM161B as a potential biomarker of disease in humans.
El Yacoubi M, Altersitz C, Latapie V, Rizkallah E, Arthaud S, Bougarel L, Pereira M, Wierinckx A, El-Hage W, Belzeaux R, Turecki G, Svenningsson P, Martin B, Lachuer J, Vaugeois JM, Jamain S. El Yacoubi M, et al. Among authors: rizkallah e. Neuropsychopharmacology. 2024 Jun;49(7):1129-1139. doi: 10.1038/s41386-024-01811-8. Epub 2024 Feb 7. Neuropsychopharmacology. 2024. PMID: 38326457 Free article.
Cannabidiol effects on cognition in individuals with cocaine use disorder: Exploratory results from a randomized controlled trial.
Rizkallah E, Mongeau-Pérusse V, Lamanuzzi L, Castenada-Ouellet S, Stip E, Juteau LC, Brissette S, Bruneau J, Dubreucq S, Jutras-Aswad D. Rizkallah E, et al. Pharmacol Biochem Behav. 2022 May;216:173376. doi: 10.1016/j.pbb.2022.173376. Epub 2022 Mar 31. Pharmacol Biochem Behav. 2022. PMID: 35367279 Free article. Clinical Trial.
Cannabidiol Effect on Anxiety Symptoms and Stress Response in Individuals With Cocaine Use Disorder: Exploratory Results From a Randomized Controlled Trial.
Mongeau-Pérusse V, Rizkallah E, Morissette F, Brissette S, Bruneau J, Dubreucq S, Gazil G, Trépanier A, Jutras-Aswad D. Mongeau-Pérusse V, et al. Among authors: rizkallah e. J Addict Med. 2022 Sep-Oct 01;16(5):521-526. doi: 10.1097/ADM.0000000000000959. Epub 2022 Feb 8. J Addict Med. 2022. PMID: 35135986 Clinical Trial.
Exploring cannabidiol effects on inflammatory markers in individuals with cocaine use disorder: a randomized controlled trial.
Morissette F, Mongeau-Pérusse V, Rizkallah E, Thébault P, Lepage S, Brissette S, Bruneau J, Dubreucq S, Stip E, Cailhier JF, Jutras-Aswad D. Morissette F, et al. Among authors: rizkallah e. Neuropsychopharmacology. 2021 Nov;46(12):2101-2111. doi: 10.1038/s41386-021-01098-z. Epub 2021 Jul 30. Neuropsychopharmacology. 2021. PMID: 34331010 Free PMC article. Clinical Trial.
32 results